The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,525
A MODIFICATION OF RECEPTOR THEORY
STEPHENSON, R. P. (1956) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1956.tb00006.x · Cited by 1,156
Operational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
Agonist-receptor efficacy II: agonist trafficking of receptor signals
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89032-x · Cited by 657
Self-citationG-Protein-coupled receptor oligomerization and its potential for drug discovery
George, S. R., O'Dowd, B. F., & Lee, S. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd913 · Cited by 588
A FlAsH-based FRET approach to determine G protein–coupled receptor activation in living cells
Hoffmann, C., Gaietta, G., Bünemann, M., Adams, S. R., Oberdorff-Maass, S., Behr, B., Vilardaga, J.-P., Tsien, R. Y., Ellisman, M. H., & Lohse, M. J. (2005) · Nature Methods · doi:10.1038/nmeth742 · Cited by 481
Regulation of G Protein-Coupled Receptor Kinases and Arrestins During Receptor Desensitization
Kohout, T. A., & Lefkowitz, R. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.9 · Cited by 449
Real-time monitoring of receptor and G-protein interactions in living cells
Galés, C., Rebois, R. V., Hogue, M., Trieu, P., Breit, A., Hébert, T. E., & Bouvier, M. (2005) · Nature Methods · doi:10.1038/nmeth743 · Cited by 419
Mack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1215 · Cited by 405
Wu, L., LaRosa, G., Kassam, N., Gordon, C. J., Heath, H., Ruffing, N., Chen, H., Humblias, J., Samson, M., Parmentier, M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1373 · Cited by 357
Ehlert, F. J. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13145-3 · Cited by 351
Ligand-selective receptor conformations revisited: the promise and the problem
Kenakin, T. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00167-6 · Cited by 321
Self-citationDrug Efficacy at G Protein–Coupled Receptors
Kenakin, T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091401.113012 · Cited by 316
Self-citationHIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use
Trkola, A., Kuhmann, S. E., Strizki, J. M., Maxwell, E., Ketas, T., Morgan, T., Pugach, P., Xu, S., Wojcik, L., Tagat, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012519099 · Cited by 303
Watson, C., Jenkinson, S., Kazmierski, W., & Kenakin, T. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008565 · Cited by 302
Self-citationEfficacy at g-protein-coupled receptors
Kenakin, T. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd722 · Cited by 263
Self-citationBrady, A. E., & Limbird, L. E. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00239-x · Cited by 263
GP120: Biologic Aspects of Structural Features
Poignard, P., Saphire, E. O., Parren, P. W., & Burton, D. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.253 · Cited by 249
Jakubík, J., Bačáková, L., El-Fakahany, E. E., & Tuček, S. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.172 · Cited by 228
Maeda, K., Nakata, H., Koh, Y., Miyakawa, T., Ogata, H., Takaoka, Y., Shibayama, S., Sagawa, K., Fukushima, D., Moravek, J., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8654-8662.2004 · Cited by 221
A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3
Sabroe, I., Peck, M. J., Van Keulen, B. J., Jorritsma, A., Simmons, G., Clapham, P. R., Williams, T. J., & Pease, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908864199 · Cited by 219
Alkhatib, G., Locati, M., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1997) · Virology · doi:10.1006/viro.1997.8673 · Cited by 210
Tsamis, F., Gavrilov, S., Kajumo, F., Seibert, C., Kuhmann, S., Ketas, T., Trkola, A., Palani, A., Clader, J. W., Tagat, J. R., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5201-5208.2003 · Cited by 203
Kuhmann, S. E., Pugach, P., Kunstman, K. J., Taylor, J., Stanfield, R. L., Snyder, A., Strizki, J. M., Riley, J., Baroudy, B. M., Wilson, I. A., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2790-2807.2004 · Cited by 196
Endocytosis and Recycling of the HIV Coreceptor Ccr5
Signoret, N., Pelchen-Matthews, A., Mack, M., Proudfoot, A. E. I., & Marsh, M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1281 · Cited by 189
Activation-independent Parathyroid Hormone Receptor Internalization Is Regulated by NHERF1 (EBP50)
Sneddon, W. B., Syme, C. A., Bisello, A., Magyar, C. E., Rochdi, M. D., Parent, J.-L., Weinman, E. J., Abou-Samra, A. B., & Friedman, P. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306019200 · Cited by 168
Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery
Pommier, Y., & Cherfils, J. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.008 · Cited by 165
Blanpain, C., Doranz, B. J., Bondue, A., Govaerts, C., Leener, A. D., Vassart, G., Doms, R. W., Proudfoot, A. E. J., & Parmentier, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205684200 · Cited by 157
Demo, A. G., Moss, R. B., Margolick, J. B., Cleghorn, F. R., Sill, A. M., Blattner, W. A., Cocchi, F., Carlo, D. J., DeVico, A. L., & Gallo, R. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11986 · Cited by 137
The ligand paradox between affinity and efficacy: can you be there and not make a difference?
Kenakin, T., & Onaran, H. O. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02036-9 · Cited by 129
Self-citationUllum, H., Cozzi‐Lepri, A., Victor, J., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/514192 · Cited by 128
Identification of Allosteric Peptide Agonists of CXCR4
Sachpatzidis, A., Benton, B. K., Manfredi, J. P., Wang, H., Hamilton, A. D., Dohlman, H. G., & Lolis, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204667200 · Cited by 117
Lalezari, J. P., Thompson, M., Kumar, P., Piliero, P. J., Davey, R. T., Patterson, K. B., Shachoy‐Clark, A., Adkison, K. K., Demarest, J. F., Lou, Y., et al. (2005) · AIDS · doi:10.1097/01.aids.0000183633.06580.8a · Cited by 112
Thomas, W. G., Qian, H., Chang, C.-S., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2893 · Cited by 104
Watson, C., Chen, G., Irving, P. E., Way, J. M., Chen, W.-J., & Kenakin, T. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1230 · Cited by 103
Self-citationAgonist-induced Endocytosis of CC Chemokine Receptor 5 Is Clathrin Dependent
Signoret, N. Y. M., Hewlett, L. J., Wavre‐Shapton, S. T., Pelchen–Matthews, A., Oppermann, M., & Marsh, M. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0687 · Cited by 102
Conformational changes and drug action.
Burgen, A. S. (1981) · PubMed · Cited by 90
An integrative biology approach for analysis of drug action in models of human vascular inflammation
Kunkel, E. J., Dea, M., Ebens, A. J., Hytopoulos, E., Melrose, J. E., Nguyen, D., Ota, K. S., Plavec, I., Wang, Y.-K., Watson, S. R., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-1538fje · Cited by 82
Kunkel, E., Plavec, I., Nguyen, D., Melrose, J. E., Rosler, E., Kao, L., Wang, Y.-E., Hytopoulos, E., Bishop, A. C., Bateman, R., et al. (2004) · Assay and drug development technologies · doi:10.1089/adt.2004.2.431 · Cited by 77
Signal transduction by calcitonin
Horne, W. C., Shyu, J., Chakraborty, M., & Baron, R. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(95)92521-j · Cited by 44
AGS proteins, GPR motifs and the signals processed by heterotrimeric G proteins
Lanier, S. M. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.03.012 · Cited by 37
AGS proteins, GPR motifs and the signals processed by heterotrimeric G proteins
Lanier, S. M. (2004) · Biology of the Cell · doi:10.1111/j.1768-322x.2004.tb01428.x · Cited by 26
Cited by
Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S., & Roth, B. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700293104 · Cited by 2,046
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Niswender, C. M., & Conn, P. J. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145533 · Cited by 1,892
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Serhan, C. N. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141647 · Cited by 997
Metadata
- Authors
- Kenakin, T.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-11
- Volume
- 4
- Issue
- 11
- Pages
- 919-927
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2072532414
- Cited by
- 317
- References
- 48
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.